<p>据报道，<strong>唐纳德·特朗普</strong> 总统计划倡导大幅放松联邦对大麻的监管，这一举措可能对该行业产生重大影响。</p>
<h2>将大麻转为第三类药物的计划</h2>
<p>特朗普预计将指示联邦机构将大麻重新分类为第三类药物，《华盛顿邮报》 周四报道。这将使该植物及其衍生物与一些处方止痛药和其他药物处于同一类别，从而减少联邦监管。</p>
<p>目前，大麻被分类为第一类药物，与海洛因和 LSD 同属一类。然而，由于数十个州和华盛顿特区已合法化医疗大麻项目，24 个州已批准娱乐性大麻，因此获取大麻变得容易。</p>
<p>据报道，总统在最近的一次电话中与众议院议长 <strong>迈克·约翰逊</strong>（R-LA）讨论了这一计划。这一变化不会使大麻合法化或非刑事化，但将扩大研究的获取渠道，并可能增加持牌企业的利润。</p>
<p>特朗普此前在八月份曾表示对重新分类感兴趣，并打算完成前总统 <strong>乔·拜登</strong> 下的进程。</p>
<p><em><strong>另见： 埃隆·马斯克声称特斯拉的机器人将 ‘只会跟着你’ 以阻止犯罪——一个你可以 ‘做任何事’ 但不能违法的无监狱未来</strong></em></p>
<h2>政策变动预示大麻政策重大转变</h2>
<p>这一潜在的重新分类可能会产生重大影响，尤其是在最近监管变化的背景下。11 月，国会通过了一项资金法案，其中包括重新刑事化几种含 THC 和大麻衍生产品的条款，引发了行业的担忧。</p>
<p>然而，尽管面临这些监管阻力，一些大麻股票 如 <strong>Tilray Brands Inc.</strong> (NASDAQ: TLRY)、<strong>Cronos Group Inc.</strong> (NASDAQ: CRON)、<strong>Organigram Global Inc.</strong> (NASDAQ: OGI) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 仍然继续在 <strong>Benzinga Edge 动量排名</strong> 中表现出改善。</p>
<p>特朗普的潜在支持被 <strong>金·里弗斯</strong>，<strong>Trulieve Cannabis Corp</strong>（OTC: TCNNF）首席执行官和 NCR 副主席称为大麻政策的 “海洋变革”。</p>
<p><strong>接下来阅读：</strong></p>
<ul>
<li>斯科特·贝森特抨击 ‘美国查维斯主义者’ 伊丽莎白·沃伦，称其驱逐外国投资：她正在破坏特朗普的 ‘黄金时代’</li>
</ul>
<p><em>图片来源于 Shutterstock</em></p>
<p><strong>_免责声明：</strong> <em>此内容部分由 AI 工具生成，并由 Benzinga 编辑审核和发布。</em></p>

TLRY

CRON

<p>特朗普总统 reportedly 计划倡导将大麻重新分类为第三类物质，从而放宽联邦法规。这一举措可能会通过扩大研究访问和增加持牌企业的利润来影响大麻行业。重新分类并不会使大麻合法化或非刑事化，但标志着大麻政策的重大转变。尽管面临监管挑战，像 Tilray 和 Cronos 这样的 cannabis 股票已经显示出改善。行业领导者认为，特朗普的潜在支持被视为政策的重大变化</p>

<p>President <strong>Donald Trump</strong> is reportedly planning to advocate for a significant relaxation of federal regulations on marijuana, a move that could have a substantial impact on the industry.</p>
<div class="lb-trans"><p>据报道，<strong>唐纳德·特朗普</strong> 总统计划倡导大幅放松联邦对大麻的监管，这一举措可能对该行业产生重大影响。</p>
</div><h2>Plan to Shift Marijuana to Schedule III</h2>
<div class="lb-trans"><h2>将大麻转为第三类药物的计划</h2>
</div><p>Trump is expected to direct federal agencies to reclassify marijuana as a Schedule III substance, The Washington Post reported on Thursday. This would place the plant and its derivatives in the same category as some prescription painkillers and other drugs, resulting in reduced federal oversight.</p>
<div class="lb-trans"><p>特朗普预计将指示联邦机构将大麻重新分类为第三类药物，《华盛顿邮报》 周四报道。这将使该植物及其衍生物与一些处方止痛药和其他药物处于同一类别，从而减少联邦监管。</p>
</div><p>Marijuana is currently classified as a Schedule I substance, the same classification as heroin and LSD. It has become easy to obtain, however, as dozens of states and Washington, D.C., have legalized medical marijuana programs, and 24 have approved recreational marijuana.</p>
<div class="lb-trans"><p>目前，大麻被分类为第一类药物，与海洛因和 LSD 同属一类。然而，由于数十个州和华盛顿特区已合法化医疗大麻项目，24 个州已批准娱乐性大麻，因此获取大麻变得容易。</p>
</div><p>The president discussed this plan with House Speaker <strong>Mike Johnson</strong> (R-LA) in a recent phone call, according to the report. The change wouldn't legalize or decriminalize marijuana, but it would expand research access and likely increase profits for licensed businesses.</p>
<div class="lb-trans"><p>据报道，总统在最近的一次电话中与众议院议长 <strong>迈克·约翰逊</strong>（R-LA）讨论了这一计划。这一变化不会使大麻合法化或非刑事化，但将扩大研究的获取渠道，并可能增加持牌企业的利润。</p>
</div><p>Trump had previously expressed interest in reclassification in August and intended to finish the process started under former President <strong>Joe Biden</strong>.</p>
<div class="lb-trans"><p>特朗普此前在八月份曾表示对重新分类感兴趣，并打算完成前总统 <strong>乔·拜登</strong> 下的进程。</p>
</div><p><em><strong>See Also: Elon Musk Claims Tesla’s Robot Will ‘Just Follow You Around’ To Stop Crimes — A Prison-Free Future Where You Can ‘Do Anything’ Except Break The Law</strong></em></p>
<div class="lb-trans"><p><em><strong>另见： 埃隆·马斯克声称特斯拉的机器人将 ‘只会跟着你’ 以阻止犯罪——一个你可以 ‘做任何事’ 但不能违法的无监狱未来</strong></em></p>
</div><h2>Policy Moves Signal Major Cannabis Shift</h2>
<div class="lb-trans"><h2>政策变动预示大麻政策重大转变</h2>
</div><p>This potential reclassification could have a significant impact, especially in light of recent regulatory changes. In November, Congress passed a funding bill that included a provision to re-criminalize several THC-infused and hemp-derived products, sparking concern across the industry.</p>
<div class="lb-trans"><p>这一潜在的重新分类可能会产生重大影响，尤其是在最近监管变化的背景下。11 月，国会通过了一项资金法案，其中包括重新刑事化几种含 THC 和大麻衍生产品的条款，引发了行业的担忧。</p>
</div><p>However, despite these regulatory headwinds, several cannabis stocks like <strong>Tilray Brands Inc.</strong> (NASDAQ: TLRY), <strong>Cronos Group Inc.</strong> (NASDAQ: CRON), <strong>Organigram Global Inc.</strong> (NASDAQ: OGI), and <strong>SNDL Inc.</strong> (NASDAQ: SNDL) have continued to demonstrate improvement in <strong>Benzinga Edge momentum rankings</strong>.</p>
<div class="lb-trans"><p>然而，尽管面临这些监管阻力，一些大麻股票 如 <strong>Tilray Brands Inc.</strong> (NASDAQ: TLRY)、<strong>Cronos Group Inc.</strong> (NASDAQ: CRON)、<strong>Organigram Global Inc.</strong> (NASDAQ: OGI) 和 <strong>SNDL Inc.</strong> (NASDAQ: SNDL) 仍然继续在 <strong>Benzinga Edge 动量排名</strong> 中表现出改善。</p>
</div><p>Trump’s potential endorsement was called a “sea change” in cannabis policy by <strong>Kim Rivers</strong>, CEO of <strong>Trulieve Cannabis Corp</strong>(OTC: TCNNF) and vice chair of NCR.</p>
<div class="lb-trans"><p>特朗普的潜在支持被 <strong>金·里弗斯</strong>，<strong>Trulieve Cannabis Corp</strong>（OTC: TCNNF）首席执行官和 NCR 副主席称为大麻政策的 “海洋变革”。</p>
</div><p><strong>READ NEXT:</strong></p>
<div class="lb-trans"><p><strong>接下来阅读：</strong></p>
</div><ul>
<li>Scott Bessent Slams ‘American Chavista’ Elizabeth Warren For Driving Away Foreign Investment: Says She Is Undermining Trump’s ‘Golden Age’</li>
</ul>
<div class="lb-trans"><ul>
<li>斯科特·贝森特抨击 ‘美国查维斯主义者’ 伊丽莎白·沃伦，称其驱逐外国投资：她正在破坏特朗普的 ‘黄金时代’</li>
</ul>
</div><p><em>Image via Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源于 Shutterstock</em></p>
</div><p><strong><em>Disclaimer</em>:</strong> <em>This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</em></p>
<div class="lb-trans"><p><strong>_免责声明：</strong> <em>此内容部分由 AI 工具生成，并由 Benzinga 编辑审核和发布。</em></p>
</div>

据报道，特朗普计划进行重大调整以放宽联邦大麻法规